Parents and caregivers can attest: feeding a baby is no easy feat, and often comes with a learning curve. In the wake of the ByHeart formula recall and the recent infant botulism outbreak linked to ...

The U.S. Food and Drug Administration (FDA) has issued two new draft guidance documents on pediatric drug development and exclusivity, most notably clarifying that, under a new proposed policy that ...

Only an estimated 5 percent of rare pediatric diseases have a treatment, although collectively they affect more than ten million children in the US. To stimulate drug development for rare pediatric ...